{"id":2724,"date":"2026-07-08T08:03:09","date_gmt":"2026-07-08T08:03:09","guid":{"rendered":"https:\/\/www.iforbes.cz\/?p=2724"},"modified":"2026-07-08T08:03:09","modified_gmt":"2026-07-08T08:03:09","slug":"prodat-vyzkum-nebo-riskovat-samostatne-pred-jakou-strategickou-krizovatkou-stoji-vedeni-abivaxu","status":"publish","type":"post","link":"https:\/\/www.iforbes.cz\/index.php\/2026\/07\/08\/prodat-vyzkum-nebo-riskovat-samostatne-pred-jakou-strategickou-krizovatkou-stoji-vedeni-abivaxu\/","title":{"rendered":"Prodat v\u00fdzkum, nebo riskovat samostatn\u011b: P\u0159ed jakou strategickou k\u0159i\u017eovatkou stoj\u00ed veden\u00ed Abivaxu?"},"content":{"rendered":"\n

Akcie francouzsk\u00e9 biotechnologick\u00e9 spole\u010dnosti Abivax p\u0159edvedly na burze dynamickou trajektorii, kter\u00e1 ilustruje extr\u00e9mn\u00ed citlivost tohoto sektoru na interpretaci medic\u00ednsk\u00fdch dat. Pot\u00e9, co se tr\u017en\u00ed hodnota pa\u0159\u00ed\u017esk\u00e9 firmy za\u010d\u00e1tkem m\u011bs\u00edce, konkr\u00e9tn\u011b 2. \u010dervna, propadla o masivn\u00edch 44 %, p\u0159ineslo \u00fatern\u00ed obchodov\u00e1n\u00ed prudk\u00fd obrat. Kr\u00e1tce po otev\u0159en\u00ed trhu akcie Abivaxu vzrostly p\u0159ibli\u017en\u011b o 25 %.* Tento n\u00e1hl\u00fd obrat n\u00e1lady investor\u016f p\u0159\u00edmo navazuje na zve\u0159ejn\u011bn\u00ed nov\u00fdch aktualizovan\u00fdch v\u00fdsledk\u016f k jej\u00edmu kl\u00ed\u010dov\u00e9mu vyv\u00edjen\u00e9mu l\u00e9ku, kter\u00e9 situaci prozat\u00edm uklidnily. Co bude d\u00e1l?<\/p>\n\n\n\n

Obefazimod a statistick\u00fd obrat<\/strong><\/p>\n\n\n\n

J\u00e1drem vysok\u00e9 volatility je experiment\u00e1ln\u00ed molekula obefazimod, kter\u00e1 p\u0159edstavuje hlavn\u00edho produktov\u00e9ho kandid\u00e1ta spole\u010dnosti Abivax. P\u016fvodn\u00ed \u010dervnov\u00fd v\u00fdprodej vyvolaly p\u0159edb\u011b\u017en\u00e9 zpr\u00e1vy z klinick\u00e9ho testov\u00e1n\u00ed, kdy investo\u0159i reagovali na informaci, \u017ee u pacient\u016f u\u017e\u00edvaj\u00edc\u00edch nejvy\u0161\u0161\u00ed d\u00e1vku tohoto l\u00e9ku se objevily p\u0159\u00edpady rakoviny.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

V\u00fdkonnost ceny akci\u00ed spole\u010dnosti Abivax za posledn\u00edch 5 let* Zdroj: TradingView<\/p>\n\n\n\n

Nov\u00e1 podrobn\u00e1 aktualizace zve\u0159ejn\u011bn\u00e1 v pond\u011bl\u00ed ve\u010der v\u0161ak p\u0159inesla z\u00e1sadn\u00ed statistick\u00fd obrat. \u0160lo o data z druh\u00e9, udr\u017eovac\u00ed \u010d\u00e1sti pozdn\u00ed t\u0159et\u00ed f\u00e1ze klinick\u00e9ho zkou\u0161en\u00ed (Phase 3 maintenance study), kter\u00e1 b\u011bhem 44 t\u00fddn\u016f testovala m\u00edru remise u pacient\u016f s ulcer\u00f3zn\u00ed kolitidou. Podle zp\u0159esn\u011bn\u00fdch v\u00fdsledk\u016f byl v\u00fdskyt zhoubn\u00fdch n\u00e1dor\u016f ve sledovan\u00e9 skupin\u011b pln\u011b v souladu s o\u010dek\u00e1vanou b\u011b\u017enou m\u00edrou v\u00fdskytu v cel\u00e9 populaci. Toto zji\u0161t\u011bn\u00ed efektivn\u011b neutralizovalo obavy, \u017ee by l\u00e9k nesl ne\u00fam\u011brn\u011b zv\u00fd\u0161en\u00e9 onkologick\u00e9 riziko, co\u017e trh okam\u017eit\u011b p\u0159etavil do n\u00e1kupn\u00edch objedn\u00e1vek.<\/p>\n\n\n\n

Pro\u010d dobr\u00e9 v\u00fdsledky automaticky neznamenaj\u00ed \u00fasp\u011bch<\/strong><\/p>\n\n\n\n

Navzdory prudk\u00e9mu \u00fatern\u00edmu o\u017eiven\u00ed v\u0161ak analytici z investi\u010dn\u00ed banky Jefferies tlum\u00ed p\u0159ehnan\u00e1 o\u010dek\u00e1v\u00e1n\u00ed a nov\u00e1 data ozna\u010duj\u00ed sp\u00ed\u0161e za podp\u016frn\u00e1 ne\u017e p\u0159elomov\u00e1. Upozor\u0148uj\u00ed, \u017ee pro finan\u010dn\u00ed trhy m\u016f\u017ee b\u00fdt psychologicky n\u00e1ro\u010dn\u00e9 \u00fapln\u011b ignorovat p\u0159edchoz\u00ed podez\u0159en\u00ed z vedlej\u0161\u00edch \u00fa\u010dink\u016f.<\/p>\n\n\n\n

Abivax nav\u00edc jako typick\u00fd z\u00e1stupce spole\u010dnost\u00ed ve stadiu klinick\u00e9ho v\u00fdvoje (clinical-stage biotech) nar\u00e1\u017e\u00ed na limity sv\u00e9 korpor\u00e1tn\u00ed struktury. Jeliko\u017e jde o p\u0159edkomer\u010dn\u00ed firmu bez vlastn\u00ed produktov\u00e9 sob\u011bsta\u010dnosti, jej\u00ed provoz kontinu\u00e1ln\u011b spot\u0159ebov\u00e1v\u00e1 masivn\u00ed objemy hotovosti. Podnik moment\u00e1ln\u011b vykazuje omezen\u00fd kalend\u00e1\u0159 bl\u00edzk\u00fdch tr\u017en\u00edch spou\u0161t\u011b\u010d\u016f a absence bezprost\u0159edn\u00edch fundament\u00e1ln\u00edch stimul\u016f v nejbli\u017e\u0161\u00edch m\u011bs\u00edc\u00edch znamen\u00e1, \u017ee se management d\u0159\u00edve \u010di pozd\u011bji neobejde bez dal\u0161\u00ed vlny rekapitalizace nebo extern\u00edho financov\u00e1n\u00ed.<\/p>\n\n\n\n

F\u00faze a akvizice jako jedin\u00e9 strategick\u00e9 v\u00fdchodisko<\/strong><\/p>\n\n\n\n

Vzhledem k finan\u010dn\u00ed n\u00e1ro\u010dnosti fin\u00e1ln\u00edch f\u00e1z\u00ed klinick\u00e9ho testov\u00e1n\u00ed a n\u00e1sledn\u00e9ho uv\u00e1d\u011bn\u00ed l\u00e9k\u016f na glob\u00e1ln\u00ed trh se st\u00e1le \u010dast\u011bji sklo\u0148uje strategick\u00e9 \u0159e\u0161en\u00ed v podob\u011b f\u00faz\u00ed a akvizic (M&A). Abivax je v kulo\u00e1rech dlouhodob\u011b vn\u00edm\u00e1n jako atraktivn\u00ed akvizi\u010dn\u00ed c\u00edl. Na trhu se op\u011bt objevuj\u00ed neov\u011b\u0159en\u00e9 spekulace, \u017ee o pa\u0159\u00ed\u017eskou firmu a jej\u00ed obefazimod projevilo p\u0159edb\u011b\u017en\u00fd z\u00e1jem n\u011bkolik velk\u00fdch nadn\u00e1rodn\u00edch farmaceutick\u00fdch korporac\u00ed.<\/p>\n\n\n\n

Tento model je pro glob\u00e1ln\u00ed hr\u00e1\u010de z kategorie „Big Pharma“ standardn\u00edm postupem. Pro ob\u0159\u00ed firmy je ekonomicky v\u00fdhodn\u011bj\u0161\u00ed absorbovat ji\u017e rozvinut\u00fd v\u00fdzkum v pokro\u010dil\u00e9 t\u0159et\u00ed f\u00e1zi a p\u0159evz\u00edt validovan\u00e9 medic\u00ednsk\u00e9 riziko ne\u017e investovat miliardy USD do nejist\u00e9ho v\u00fdvoje vlastn\u00edch molekul od \u00fapln\u00e9ho z\u00e1kladu. Pro Abivax tak \u00fasp\u011b\u0161n\u00e9 p\u0159evzet\u00ed siln\u011bj\u0161\u00edm partnerem p\u0159edstavuje nejre\u00e1ln\u011bj\u0161\u00ed cestu, jak dostat l\u00e9k k pacient\u016fm a z\u00e1rove\u0148 uspokojit n\u00e1roky akcion\u00e1\u0159\u016f.<\/p>\n\n\n\n

Ponau\u010den\u00ed pro investory<\/strong><\/p>\n\n\n\n

Sou\u010dasn\u00fd p\u0159\u00edb\u011bh spole\u010dnosti Abivax nab\u00edz\u00ed \u0161ir\u0161\u00ed ponau\u010den\u00ed o specifik\u00e1ch investov\u00e1n\u00ed do inovativn\u00ed medic\u00edny. Biotechnologick\u00fd sektor se \u0159\u00edd\u00ed p\u0159\u00edsn\u011b bin\u00e1rn\u00edmi pravidly, kde \u00fasp\u011bch nebo selh\u00e1n\u00ed z\u00e1vis\u00ed na schv\u00e1len\u00ed regula\u010dn\u00edmi \u00fa\u0159ady a interpretaci desetinn\u00fdch \u010d\u00e1rek ve statistick\u00fdch reportech. Jedin\u00e1 tiskov\u00e1 zpr\u00e1va dok\u00e1\u017ee vymazat t\u00e9m\u011b\u0159 polovinu tr\u017en\u00ed kapitalizace, aby ji n\u00e1sledn\u00e1 korekce o p\u00e1r dn\u00ed pozd\u011bji z\u010d\u00e1sti obnovila.<\/p>\n\n\n\n

Anna \u0160uhajdov\u00e1, p\u0159edsedkyn\u011b p\u0159edstavenstva <\/strong>CAPITAL MARKETS, o.c.p., a.s.<\/strong><\/a><\/p>\n\n\n\n

* \u00dadaje, kter\u00e9 se t\u00fdkaj\u00ed minulosti, nejsou z\u00e1rukou budouc\u00edch v\u00fdnos\u016f.<\/p>\n\n\n\n

Upozorn\u011bn\u00ed! Tento marketingov\u00fd materi\u00e1l nen\u00ed a nesm\u00ed b\u00fdt ch\u00e1p\u00e1n jako investi\u010dn\u00ed poradenstv\u00ed. \u00dadaje, kter\u00e9 se t\u00fdkaj\u00ed minulosti, nejsou z\u00e1rukou budouc\u00edch v\u00fdnos\u016f. Investov\u00e1n\u00ed v ciz\u00ed m\u011bn\u011b m\u016f\u017ee ovlivnit v\u00fdnosy v d\u016fsledku v\u00fdkyv\u016f. Ve\u0161ker\u00e9 obchody s cenn\u00fdmi pap\u00edry mohou v\u00e9st jak k zisk\u016fm, tak i ke ztr\u00e1t\u00e1m. V\u00fdhledov\u00e1 prohl\u00e1\u0161en\u00ed p\u0159edstavuj\u00ed p\u0159edpoklady a aktu\u00e1ln\u00ed o\u010dek\u00e1v\u00e1n\u00ed, kter\u00e1 nemus\u00ed b\u00fdt p\u0159esn\u00e1, nebo vych\u00e1zej\u00ed z aktu\u00e1ln\u00edho ekonomick\u00e9ho prost\u0159ed\u00ed, kter\u00e9 se m\u016f\u017ee zm\u011bnit. Tato prohl\u00e1\u0161en\u00ed nezaru\u010duj\u00ed budouc\u00ed v\u00fdkonnost. Spole\u010dnost CAPITAL MARKETS, o.c.p., a.s. je subjekt regulovan\u00fd N\u00e1rodn\u00ed bankou Slovenska.<\/p>\n\n\n\n

Zdroje:<\/p>\n\n\n\n

https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/7593b053-a1e9-49bc-9802-6abd83455ef9<\/a><\/p>\n\n\n\n

https:\/\/www.cnbc.com\/2026\/06\/30\/abivax-stock-trial-data-biotech-obefazimod.html<\/a><\/p>\n\n\n\n

https:\/\/www.cnbc.com\/2026\/06\/02\/abivax-stock-bowel-crohns-disease-trial-data.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Akcie francouzsk\u00e9 biotechnologick\u00e9 spole\u010dnosti Abivax p\u0159edvedly na burze dynamickou trajektorii, kter\u00e1 ilustruje extr\u00e9mn\u00ed citlivost tohoto sektoru na interpretaci medic\u00ednsk\u00fdch dat.<\/p>\n","protected":false},"author":1,"featured_media":2538,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout"},"categories":[58],"tags":[],"_links":{"self":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts\/2724"}],"collection":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/comments?post=2724"}],"version-history":[{"count":1,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts\/2724\/revisions"}],"predecessor-version":[{"id":2726,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts\/2724\/revisions\/2726"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/media\/2538"}],"wp:attachment":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/media?parent=2724"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/categories?post=2724"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/tags?post=2724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}